AA
YCBD icon

Alesco Advisors’s cbdMD YCBD Stock Holding History

Alesco Advisors’s Portfolio YCBD Stock Details YCBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$50.8K Hold
68,513
– – ﹤0.01% 243
2025
Q4 		$92.5K Hold
68,513
– – ﹤0.01% 202
2025
Q3 		$82.9K Hold
68,513
– – ﹤0.01% 201
2025
Q2 		$61.1K Buy
+68,513
New +$89.9K ﹤0.01% 192

Other funds holding YCBD

WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CD
Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Alesco Advisors's YCBD Position: Q1 2026 in Review

Alesco Advisors held its cbdMD (YCBD) position steady in Q1 2026 at 68,513 shares worth $50.8K. The position accounts for ﹤0.01% of the portfolio, ranked #243.

Alesco Advisors first reported a position in YCBD in Q2 2025 and has held it in 4 quarters since. The position peaked at $92.5K in Q4 2025. 25 funds tracked by Wall St. Rank hold YCBD as of Q1 2026.

  • Alesco Advisors held 68,513 shares of cbdMD worth $50.8K as of Q1 2026.
  • Alesco Advisors left its cbdMD share count unchanged in Q1 2026.
  • cbdMD made up ﹤0.01% of Alesco Advisors's portfolio in Q1 2026, its #243 holding.
  • Alesco Advisors first reported a position in cbdMD in Q2 2025 and has held it in 4 quarters since.
  • Alesco Advisors's cbdMD position peaked at $92.5K in Q4 2025.
  • 25 funds tracked by Wall St. Rank held cbdMD as of Q1 2026.

Based on Alesco Advisors's 13F filing for Q1 2026, filed 13 May 2026.